Delivery Order SPE2DB22D1202-SPE2DB24FVBA6
- Not listed
- This is a $17,179.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565372242 Insulin Glargine-yfgn U100 Pen 3ML. The contract has an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564029748 - Insulin Glargine-YFGN U100 Pen 3 ML. The contract, valued at $6,590.40, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563977468 - Insulin Glargine-YFGN U100 Pen 3ML to DLA Troop Support Medical. This $4,556.89 delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to...
- This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,395.72 firm fixed price contract is for the supply of Insulin Glargine-YFGN U100 Pen 3ML, a prescription insulin product. It is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of insulin glargine-yfgn U100 pens, with a ceiling value of $3,954.24 and a performance period ending May 1, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Insulin Glargine-yfgn U100 Pen 3ML. The delivery order has a ceiling value of $2,141.88 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor, and...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order worth $1,977.12 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the delivery of INSULIN GLARGINE-YFGN U100 PEN 3ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Glargine-yfgn U100 Pen 3ML. The award has a ceiling value of $7,273.73 and a completion date of May 22, 2024. It is a firm fixed price contract and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,841.00, is for the supply of insulin glargine-yfgn U100 pens. The contract has a completion date of December 27, 2024 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Glargine-yfgn U100 Pen 3ML. The contract has a Ceiling Value of $1,575.60 and runs through January 28, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FVBA6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4564676268 INSULIN GLARGINE-YFGN U100 PEN 3ML, a pharmaceutical product. The order has a Firm Fixed Price of $2,196.80 and a completion date of May 22, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is not set aside for any specific business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 5/21/24 |